Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Small molecule treatment holds promise for Usher syndrome

Small molecule treatment holds promise for Usher syndrome

1 Jul 2011
Researchers identify new lung stem cell that helps repair large airways

Researchers identify new lung stem cell that helps repair large airways

28 Jun 2011
Researchers find potentially dangerous fungus in common household appliances

Researchers find potentially dangerous fungus in common household appliances

21 Jun 2011
Breakthrough treatment for Cystic Fibrosis sufferers with 'Celtic Gene'

Breakthrough treatment for Cystic Fibrosis sufferers with 'Celtic Gene'

20 Jun 2011
Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

20 Jun 2011
Ground breaking treatment for Cystic Fibrosis

Ground breaking treatment for Cystic Fibrosis

20 Jun 2011
Miracle cures on the horizon for genetic disease

Miracle cures on the horizon for genetic disease

17 Jun 2011
GenMark prices public offering of common stock

GenMark prices public offering of common stock

17 Jun 2011
Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD

Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD

17 Jun 2011
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis

Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis

16 Jun 2011
Serious RSV infections may occur in previously healthy infants and children

Serious RSV infections may occur in previously healthy infants and children

16 Jun 2011
FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

15 Jun 2011
Abbott’s CREON receives FDA approval for infant-specific dose

Abbott’s CREON receives FDA approval for infant-specific dose

14 Jun 2011
Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

13 Jun 2011
Vertex VX-770 Phase 3 STRIVE study for cystic fibrosis demonstrates improvements in lung function

Vertex VX-770 Phase 3 STRIVE study for cystic fibrosis demonstrates improvements in lung function

10 Jun 2011
Study links mutations in essential genes with orphan diseases

Study links mutations in essential genes with orphan diseases

10 Jun 2011
Promising results from VX-770 and VX-809 Phase 2 study for cystic fibrosis

Promising results from VX-770 and VX-809 Phase 2 study for cystic fibrosis

9 Jun 2011
Vertex announces interim results from VX-770 and VX-809 Phase 2 study on cystic fibrosis

Vertex announces interim results from VX-770 and VX-809 Phase 2 study on cystic fibrosis

9 Jun 2011
McGill researcher develops speedier technique for predicting protein folding pathways

McGill researcher develops speedier technique for predicting protein folding pathways

8 Jun 2011
Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

7 Jun 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback